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T-cell responses generated in vitro in mixed lymphocyte cultures are manifest first
as a proliferative phase with a peak on day 3 or 4 followed by a cytotoxic phase which
peaks on day 5. The majority of cells contributing to the proliferative phase are Ly-1-
positive T cells responding to I region determinants and they help the Ly-2+ 3+
cytotoxic cells make their optimal response, which is directed against K/D coded
antigens (1) . When one-way mixed lymphocyte cultures (MLC)' are set up between
mice differing across the whole of the H-2 complex (i.e. KISD) the target cell
specificity is such that the strongest cytotoxicity is seen against target cells of the same
H-2 haplotype as the stimulating cell, but a certain degree of cross-killing is also seen
on independent haplotypes (2, 3) . In this paper we further document and quantitate
the extent to which this type of cross-reactive kill is seen and compare it with the
cross-reactive kill seen when cytotoxic responses are elicited between H-2b and H-2b
mutant strains. The cross-reactivities elicited in both these ways is contrasted with the
very specific H-2 restricted cytotoxicity obtained by priming H-2b female mice in
vivo and boosting them in vitro in MLC with male spleen cells (4) .
Materials and Methods
Mice were obtained either from the Division of Comparative Medicine, Clinical Research
Centre, or The Jackson Laboratory, Bar Harbor, Maine.
MLC. MLC were set up in Falcon flasks (BioQuest, BBL & Falcon Products, Becton,
Dickinson & Co., Cockeysville, Md.) (25 cm3) using equal numbers of responder spleen cells,
and 2,000 rads irradiated stimulator spleen cells, each at a concentration of 5 X 106/ml in
RPMI-1640 medium containing 10% fetal calf serum (FCS), 5 X 10-5 M 2 mercaptoethanol,
10 mM Hepes, glutamine, penicillin, and streptomycin. MLC flasks contained a total of 20 ml
cell suspension, and were incubated upright in a humidified atmosphere with 10% C02, at
37°C for 5 days. They were then harvested and assayed for cytotoxicity. All anti-allogeneic and
anti-H-2b mutant MLC were primary responses. All anti-H-Y MLC were secondary responses,
after in vivo priming 2 wk-5 mo before in vitro boosting, with syngeneic male spleen cells.
Target cells were prepared 48 or 72 h before the assay by removing erythrocytes from freshly
teased spleen cell suspensions using Gey's hemolytic medium (5) and then incubating them in
4 hg/ml Concanavalin A in the RPMI medium described above, at a concentration of 4-5 X
* Present address: Department of Bacteriology and Immunology, University of Helsinki, Finland.
$ Supported by an Arthritis Clinical Research Center grant, and the Department ofMedicine, University
ofVirginia School of Medicine, Charlottesville, Va.
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106/ml, using 20 ml per Falcon flask. The target cell cultures were incubated at 37°C in a
humidified atmosphere containing 10% CO2.
The 5'Cr release assay was essentially as previously described (5) . 1 X 10'-2 X 10' target
cells were labeled for 90 min at 37°C in 1 ml balanced salt solution (BSS) containing 5% FCS,
with 100 uCi 51Cr. They were then washed twice in a large volume (50 ml) BSS/5% FCS,
counted, and resuspended in Eagle's minimal essential medium (Gibco 109G, Grand Island
Biological Co., Grand Island, N.Y.) containing 10% FCS and 10 mM Hepes, at an appropriate
concentration (usually between 1 X 105 and 1 X 106/ml) chosen so that the attacking cells
could be assayed at four different attackentarget (A:T) cell ratios, ranging from 20:1 down.
0.1-ml target cells were placed in wells in microtitre plates (most of the. experiments reported
here were done using flat-bottomed wells for the assay, but round-bottomed wells serve equally
well) . 0.1-ml attacking cells at four different, halving dilutions were then added to the target
cells. There were three replicates for each A:T ratio. Maximum release was determined by
adding 5% Triton to each of three wells containing target cells, and control, spontaneous release
was determined by incubating target cells in each of three wells in medium alone. The plates
were centrifuged immediately after addition of attackers and targets, at 500 rpm for 5 min and
then incubated for 3 h at 37°C in a humidified atmosphere containing 10% CO2. The plates
were then centrifuged again for 10 min at 1,000 rpm. An aliquot of the supernates (usually 100
g,l) was then removed using an Eppendorf pipette, and the "Cr released into the supernate was
determined using a gamma counter. The percent-specific release was determined according to
the formula given in (5) and then regression analysis applied to the specific lysis values at each
of the 4 A:T ratios. From the regression lines obtained, the value of specific lysis at a ratio of
10:1 or 4:1 was read, r2 values of each of the regression lines were obtained, and results only
accepted as positive where this value, indicating the goodness of fit of the four experimentally
determined points to the line, lay between 0.9 and 1 .0.
Skin grafting was carried out according to the method of Billingham (6), using tail skin
grafts placed on a graft bed prepared on the thorax of the recipient. Grafts were read daily
after removing the plasters on day 8 after grafting and the end point scored when less than 10%
viable skin was evident in the graft.
In vivo priming to the male-specific antigen, H-Y, was done by injecting female H-26 mice
with 107 syngeneic male spleen cells 2 wk to several months before use in MLC (4).
Results
Tables I and II show the results of four experiments each where cytotoxicity
generated in MLC between B lO.S responders and B10 X-irradiated stimulator spleen
cells (Table I) and between B 10.G responders and B 10 stimulators (Table II) was
assayed against the specific target B10, and against spleen cells from a variety of
different strains, representing 4 of H-2k haplotype, three of H-2 d haplotype, and one
each H-2' and H-2f. Several points can be made from these data: first, there is a
correlation between the level of kill against the specific target and that against the
targets showing cross-reactive kill ; where the one is high, so, comparatively, are the
others, and conversely, when specific kill is relatively low, much less cross-reactive
cytotoxicity is seen. Second, the level of cross-reactive kill against different strains of
the same H-2 haplotype is comparable, within any one experiment, but there is an
occasional exception, such as the failure to cross kill CBA targets in experiment 4,
Table II, and the low kill by those same attackers against DBA/2 targets, in
comparison with BALB/c and B 10.132 targets. Third, there is effectively no autokilling
of targets syngeneic with the attackers. This third point is also made in Table III,
where the cross-reactive killing by Ft cells is restricted, so that neither parental strain
cells are killed.
That the cross-reactive killing as well as the specific killing is mediated by T cells
is shown in Table IV, which is the result of assaying the same attacking cells shown1480
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TABLE I
Specificity ofH-28 Anti-H-28 Responses
Cytotoxicity' on target cells
Cytotoxicity at A:Tcell ratio 10:l, taken from a regression curve, see Materials and Methods.
No, Not done.
in Table I, experiment 2, after treatment with anti-Thy 1 .2 plus complement, there
is complete abrogation of all cytotoxicity, against every target, after this treatment.
Tables Va and b indicate that it is unlikely that the target antigens of the cross-
reactive cytotoxicity are the public antigens identified serologically. Table Va lists the
public specificities against which responses might be directed in an H-2° anti-H-2°
response, and in an H-28 anti-H-2b response. Below this are listed the public H-2
specificities of the independent haplotypes k, q, d, s, r, b, and f. This information is
taken from Klein (7) . From the information in Table Va, the predictions of Table Vb
can be made. The most important and easily tested predictions are the negative ones,
i.e. that H-2k and H-2' targets should not be cross-killed by either q anti-b or s anti-
b if serologically identified public specificities are the target antigens. However, it can
be seen from Tables I and II that these predictions are not fulfilled, because both H-
2k and H-2' targets are killed by both attackers. These results would appear to rule
out the possibility that known serologically identified public antigens are targets for
T-cell cytotoxicity, and may indicate that cytotoxic T cells have a different repertoire
of reactivities from B cells, a point which has recently been made in an analysis of
cytotoxic responses among H-2b mutant strains (8) . It could be argued that the
cytotoxicity generated between two strains which differ across the whole MHC,
including I as well as K/D differences, could be also directed against I region
determinants, and that the cross-reactivities seen might be due to shared la specifici-
ties. That this is not the sole explanation of cross-reactive cytotoxicity is shown by
experiments reported in Table VI, where cytotoxic responses were generated between
H-2b and H-2b mutant strains. The H-2b' and H-2f mice are H-2Kb mutants, and H-
2b, is an H-2Db mutant (9, 10) . the mutational events are thought to be restricted to
the K or D end coded molecule, respectively, and certainly there is no evidence of any
I region involvement (9, 10) . Nevertheless, the high level ofcytotoxicity shown against
the specific target (first column) is also accompanied by cross-reactivity against target
cells of H-2k/d, H-2d
, H-2a, H-2f H-2k/q, and H-2' haplotypes.
From the experiments reported above, both with anti-allogeneically induced cyto-
toxic responses, and with anti-K/D mutant cytotoxic responses, it would seem that if
the MLC response is the in vitro correlate of graft rejection, then cross-priming for
second-set graft rejection should be seen . There is already one report that this may be
so (11), by judging histological evaluation of the second grafts early during the
rejection process. We set up further experiments to investigate this point, with
conventional macroscopic evaluation of second skin grafts to determine the median
Exp. H-2k H-2"
H-2r H-2t
Bl0 B10.S BIORIN BIO.M
B10.BR C3H CBA AKR B10.D2/ BALB/c DBA/2
l 34.1 ± 0.5 1.5 t 3.9 10.0 t 1 .4 13.7 t 2.1 NDt ND 4.5 t 0.9 ND ND ND ND
2 17.8 ± 2.1 1.1 t 0.5 8.7 t 1 .7 ND No ND 5.2 t 1.8 ND ND ND ND
3 40.4±1 .1 1.0±0.923.9±2.1 ND 27.8±1.9 ND 25.1±0.2 ND ND 17.8±0.4 1.0±1.3
4 28.9 ± 1 .7 ND 16.3 t 0.9 14.6 ± 0.9 5.6 ± 0.1 7.4 ± 0.9 15.2 ± 1 .0 16.1 t 0.4 6.4 ± 0.7 ND ND
Mean 30.3 t 4.8 1.2 ± 0.2 14.7 t 3.5 14.2 t 0.5 16.7 t 11.1 7.4 t 0.9 12.5 t 4.9 16.1 t 0.4 6.4 t 0.7 17.8 t 0.4 11 .0 t 1.3'$See footnotes to Table I.
'$ See footnotes toTable I.
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TABLE II
Specificity ofH-2° Anti-H-2 6 Responses
Cytotoxicity" on target cells
TABLE III
Effect of Using Fl Responders on Cross-Reactive Cytotoxicity
survival time (MST) of these grafts. Two groups of male B 10.G mice were skin grafted
for the first time either (1) with autologous male B 10.G skin or (2) with male B10
skin. 35 days later, well after all the primary grafts in group 2 had been rejected, each
group of mice was divided in two and regrafted, on the contralateral side, with either
1110 male skin or 1310.S male skin. The results in Fig. 1 show that autologous grafting
of B 10.G mice with B lO.G skin leads to a primary rejection (MST 12.5 day) of
subsequently grafted B10 or B10.S skin; see curves (a) and (b) . Allogeneic priming of
B10.G mice with B10 skin however elicits a more rapid rejection (MST 10.5 and 9.5
day) of subsequently grafted B10 or B10.S skin ; compare curves (c) and (d) with
curves (a) and (b) indicating presensitization by the first graft . Thus it would seem
that B10 does cross-prime for a second set response to B 10.S alloantigens on skin.
Thus the in vivo data correlates with the in vitro findings of cross-reactivity at the
level of the cytotoxic cell for anti-H-2 responses. This is of interest, since control of
cytotoxicity and of graft rejection have recently been disassociated for responses to the
male specific antigen, H-Y (12) . It may be that such a disassociation for anti-H-2
responses is never seen because of the ubiquitous nature of both types of response to
H-2 antigens.
In contrast, the very fine specificity of an H-2 restricted response of various types
ofresponder mice to the male specific antigen, H-Y, is shown in Table VII. Responder
status with respect to the generation of these cytotoxic responses is associated both
with a dominant Ir gene(s) of the H-26 haplotype, mapping in IA, and with
complementary Ir genes, at least some mapping in IC, of a variety of haplotypes
which themselves are nonresponders, but which give responder Fl hybrids (13) . One
Exp.
1-[-2" H-2s
H-24 H-2e
H-2' H-2'
B10 BIO.G BIORIII BIOM
BIOAR C3H CBA AKR BIO.D2 BALB/c DBA/2
l 41.6 ± 0.6 2.6 t 2. 15.5 t 3.1 16.4 ± 1.9 ND# ND 26.2 ± 5.3 ND ND ND ND
2 34.8 ± 3.7 0.3 ± 2.1 10.7 ± 2.5 14.8 ± 3.1 ND ND 2.7 ± 3.2 ND ND ND ND
3 35.3 ± 1.2 2.6 t 2.1 15.8 ± 1.8 ND 19.3 ± 2.9 ND 19.8 ± 3.1 ND ND 9.0 ± 2.1 8.4 ± 1.2
4 34.9±1.9 ND 13.0±1.410.8±1.1 1.1±3.416.4±1 .612.2±1.713.2±1.84.9±1.9 ND ND
Mean 36.7± 1.7 1.6± 1. 13.8± 1.2 14.0± 1.7 10.2±9.1 16.4± 1.615.2±5.1 13.2± 1.8 4.9± 1.9 9.0±2.1 8.4± 1.2
Exp.L
Responders
BIo.S B10
Cytotoxicity' on target cells
BALB CBA B10.G B .0.RIII BION
B10 Anti-BIO.S 55.3 ± 2.1 0.5 ± 0.2 20.4 ± 1.4 ND# 21 .1 ± 1 .0 15.9 ± 0.1 25.4 ± 1.3
BALB Anti-BIO.S 47.4 ± 4.8 7.2 ± 1.3 0.6 ± 0.5 ND 15.8 ± 2.1 6.2 t 2.1 14.1 ± 0.3
(B10 x BALB)FI Anti-BI0.S 53.0 t 1.3 0.4 ± 0.3 1.5 ± 0.3 ND 17.4 ± 1.1 8.8 ± 0.7 15.7 ± 1.0
2 CBA Anti-BIO.S 41.5 t 0.6 32.4 ± 3.2 ND 0.7 ± 0.3 22.3 ± 1.6 14.7 t 1.3 18.5 ± 0.1
B10 Anti-B10.S 45.2 t 4.0 0.3 t 0.3 ND 49.5 ± 3.6 29.3 ± 2.1 21.7 t 1.8 34.6 ± 0.6
(B10 x CBA)F, Anti-BIO.S 54.3 t 3.0 0.7 t 0.3 ND 6.9 ± 1.0 21.5 t 2.2 17.5 t 1.6 30.1 ± 1.6
3 CBA Anti-BIO.S 41.8 ± 1.4 18.2 t 2.2 ND 0.4 t 0.5 17.1 t 0.7 24.0 t 2.6 12.7 t 0.9
BIO.G Anti-BIO.S 43.5 t 3.6 26.8 ± 4.1 ND 25.5 t 1.9 5.3 t 0.5 23.6 t 1.5 17.5 t 1.2
(CBA x BIO.G)F, Anti-Bl0.S 43.2 t 1.1 14.8 ± 2.2 ND 5..5 t 1.5 8.2 t 0.8 25.5 t 1.1 12.4 t 1.21482
TABLE IV
Effect ofAnti-Thy 1.2 Plus Complement on Cross-Reactive Cytotoxicity Shown by H-28 and H-26 MLC
Cells
SPECIFICITY OF ANTI-H-2 AND H-2 RESTRICTED CYTOTOXICITY
An Analysis ofPublic H-2 Antigens as Targetsfor Cross-Reactive Cytotoxicity
(a) The public H-2 antigens:
(b) The predictions if public specificities are targets:
H-2° Anti-H-2
b
￿
Positive
￿
H-2d and H-2' if 35/36 are targets
on
Negative H-2k and H-2'
on
H-2' Anti-H-2b ￿Positive
￿
H-2 Q if 27/28/29 are targets
on
"
￿
H-2f if 27/39 are targets
H-2f if 39/46 are targets
H-2d if 27/29/35 are targets
Negative H-2k and H-2'
on
TABLE V
Sensitizing public antigens
very marked feature of anti-H-Y responses is their propensity to be associated, in
terms of target cell specificity, with either K or D end antigens, and only rarely with
both. In this respect the responses differ somewhat from the H-2 restricted cytotoxic
responses to viruses (14) or haptens (15) which are usully associated with both K and
Sensitization
H-2QAnti-H-2b
H-2' Anti-H-2b 27
K end D end
35 36 39
29 35 39 27 29
Haplotype Public antigens of various haplotypes shared with H-2b
H-2b 5 27 28 29 35 36 39 46 6 27 28 29
H-2k 5 5
H-2° 5 6 27 28 29
H-2d 27 28 29 46 6 27 28 29 35 36
H-2' 5 6 28 36
H-2' 5 5 6
H-2r 27 39 46 6
H-2b
Cytotoxicity
H-2'
on target
H-29
cells*
H-2d H-2k
Group B10 B 10.S 1310.G B10.132 1310.13R
Untreated 17.8 t 2.1 1 .1 t 0.5 7.4 ± 1.1 5.2 t 1 .8 8.7 t 1 .7
Complement alone 22.8 t 4.4 1 .1 t 0.3 6.5 t 1.4 6.6 t 1 .5 8.6 t 1 .7
Anti-Thy 1.2 plus com- 0.0 t 0.9 0.5 t 0.9 -0.1 t 0.4 -1.2 t 0.8 0.9 t 1 .1
plement
* See footnotes on Table I.SIMPSON ET AL.
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TABLE VI
Specificity ofCytotoxicity Generated in MLC betweenH-2° Mutant Strains, and between H-2° Mutant
Strains and their Strain of Origin
Target cells
FIG . 1 .
￿
Survival curves of second skin grafts ofeither B10 (groups a and c) or B10.S (groups b and
d) placed on B10.G mice 25 days after a primary graft of syngeneic B10.G skin (a and b) or
allogeneic B10 skin (c and d) . Alldonors and recipients were male .
D antigens of any given haplotype. However, the most striking feature of these H-Y
responses is the extraordinary specificity of the H-2 restriction, thus, H-2 b (D)
associated anti-H-Y cytotoxic cells do not kill male cells of other haplotypes (exp . 1
and 2, Table VII), in marked contrast to the cross killing shown in Tables I and II,
where anti-H-2b cytotoxic cells generated from H-24 or H-2 8 cells significantly cross
killed a wide range of independent haplotypes . Likewise H-2 8 (D~ associated anti-H-
Y killer cells did not cross kill other haplotypes nor do H-2k or H-2° associated killers
cross kill (exp . 3-8, Table VII) . This is true both when one is considering the anti-H-
Y responses controlled by the dominant H-2b Ir gene(s) (exp. 1-3, 7, 8, Table VII) or
the complementary Ir gene(s) of other haplotypes (exp . 4-6) . Such data might argue
for the associative H-2 antigen for H-2 restricted cytotoxicity being the private K or
D end specificity, as defined serologically. However, this is unlikely in view of the
failure ofK andD end mutant strains, which share the same private specificity with
the strain of origin (e.g. H-2b' and H-2bf are serologically difficult to distinguish from
H-2b mice) to substitute for the strain of origin as virus infected or H-Y carrying
target cells (16, 17) . Such H-2 restricted data usingmutant mouse strains as responders
also argue for their being private specificities uniquely seen by T cells (17) . The only
H-Y responders for which the H-2 restriction is not limited to either end are those
Sensitized cells
H-2"
B6
H-2" H-2°°
H-2tia
BIO.A
H-2"
BALB/c
H-2'
A.SW
H-2`
BIOM
H-2tia
AKM
H-2'
WORM
H-2' Anti-H-2" 67 .6 2 3 .5 ND ND 14 .0 t 1 .6 ND 7 .9 t 1 .0 16.3 t 1 .4 17 .2 t 1 .6 11 .7 t 1 .2
H-2°t Anti-H-2 6 68.3 t 1 .8 ND ND 12 .2 t 0 .7 ND 8 .0 t 1 .0 18.8 t 0 .9 14 .8 t-0 .9 7 .1 t 0 .1
H-2° ' Anti-H-2" 72 .0 t 0.7 ND ND 26 .1 t 1 .3 ND 7 .9 t 0 .3 16.3 t 0 .3 35 .5 t 1 .4 7 .4 t 0 .9
H-2" Anti-H-2 M 1 .3 t 0.6 50 .8 t 2 .5 0 .1 t 0.5 ND 7 .8 t 1 .1 4 .8 t 0 .7 13 .2 t 1 .2 ND ND
H-2' Anti-H-2" 62 .9 t 3 .9 56 .4 t 3 .5 56.6 t 4 .0 ND 16.4 t 1 .1 8 .3 t 0 .5 27 .3 t 2 .1 ND ND
H-2' Anti-H-2' 60.0 t 2 .3 38 .0 t 2 .6 65 .4 t 4 .8 ND 20.4 t 0.7 8 .3 t 0 .4 20.2 t 2 .2 ND ND1484
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* Cytotoxicity at A:T cell ratio 4:1 .
TABLE VII
Specificity ofAnti-H-Y Cytotoxic Responses
Exp. Responder
Antigens in
vivo andin vi-
tro
Target cells
(haplotype)
Specific
cytotox-
icity*
Associa-
tive anti-
gen
I B104 B10& B106 (bbbbbb) 18.5 ± 1.6
bbbbbb bbbbbb B104 (bbbbbb) 2.0 t 1.3
B10A(2R)& (kkkddb) 15.8 t 1.8 Db
B10A(2R)4 (kkkddb) -1 .6 t 1.2
B10A(5R)d (bbbddd) 0.78 t 0.3
BALB/cd (dddddd) 2.3 t 0.8
2 (B10 x BALB/c)F,4 B106 B1Od (bbbbbb) 19.9 t 3.4
bbbbbb/dddddd bbbbbb B104 (bbbbbb) 1 .7 t 0.9
CBA& (kkkkkk) -3.9 t 1.1
BALB/cd (dddddd) 0.1 t 0.7 Db
Ad (kkkddd) 0.9 t 0.8
B10A(2R)d (kkkddb) 26.7 t 0.5
B10A(5R)d (bbbddd) 0.4 t 0.3
3 (B 10 x B1OS)F,4 BIOS& Bl Od (bbbbbb) 29.2 ± 0.7
bbbbbb/ssssss ssssss B104 (bbbbbb) 4.2 t 1.1
D
a
B10A(2R)d (kkkddb) 26.9 t 1.7
B10A(5R)d (bbbddd) 2.2 t 0.7
4 (CBA x BALB/c)F,4 CBA& CBAd (kkkkkk) 48.0 t 2.9
kkkkkk/dddddd kkkkkk CBA4 (kkkkkk) -2.8 t 2.0
Ad (kkkddd) 39.5 t 2.5
B10&(bbbbbb) 0.9 t 0.1 K k Dk
BIOA(4R)d (kkbbbb) 23.8 t 4.5
Bl0A(2R)d (kkkddb) 20.9 t 1.4
C3H.OHd (dddddk) 40.8 t 1 .3
BALB/cd (dddddd) 2.0 t 3.1
5 (CBA x B10.G)F,4 CBA& CBA& (kkkkkk) 16.0 t 0.6
kkkkkk/gqqqqq kkkkkk CBA4 (kkkkkk) 3.8 t 0.3
BlO.G& (qqqqqq) -1.0 t 0.7 K k Dk
AQRd (qkkddd) -3.2 t 2.4
C3H.OHd (ddddk) 12.5 t 1 .4
Ad (kkkddd) 13.7 t 0.4
6 (CBA x B10.G)F,4 B10.Gd B10.Gd (qqqqqq) 13.1 t 1 .1
kkkkkk/gqqqqq qqqqqq BlO.G4 (qqqqqq) 3.6 t 0.1
CBAS (kkkkkk) 1.0 t 0.2 D
AQRd (qkkddd) 0.5 t 1.1
C3H.OH& (ddddk) 2.2 t 1.1
Ad (kkkddd) 1.5 t 0.5
7 (B10.A x B10.A(5R))F,4 B10.Ad B10.Ad (kkkddd) 40.0 t 1.9
kkkddd/bbbddd kkkddd B10.A4 (kkkddd) -3.1 t 2.0
C3H.OHd (dddddk) 20.9 t 1.3 Kk Dk
BlO.BRd (kkkkkk) 51 .2 t 2.8
BALB/cd (dddddd) -1 .0 t 0.2
8 (B10.A x HTI)F,4 B10.A& B10.A& (kkkddd) 40.7 t 2.5
kkkddd/bbbbd kkkddd B10.A4 (kkkddd) 2.8 t 1.4
C3H.OHd (dddddk) 47.8 t 3.9 K k D k
B10.BRd (kkkkkk) 25.5 t 1.7
BlO.D2& (dddddd) 1 .9 t 1.2
B106 (bbbbbb) 3.9 t 1.1SIMPSON ET AL.
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associated with H-2k and exemplified by responses to H-2k male cells by complemen-
tary Fl hybrid females with one H-2k parent. In most cases the associative antigens
are at both ends (exp. 4, 5, 7, and 8, Table VII). An insight into a possible underlying
reason for these both-end associated responses comes from experiments, done with Fl
female mice having one B10.A parent (Table VII, exp. 7 and 8) . When such hybrids
are stimulated with B10.A male cells, they kill male targets bearing Kk antigens, fail
to kill targets bearing Dd antigens, or K or D end antigens of other independent
haplotypes, but, surprisingly, they do kill male targets bearing Dk antigens, with
which they have not been ostensibly associated during sensitization. This suggests that
there is reduplication of the Kk associative private antigen, as seen by T cells, at Dk.
Discussion
The very clear fine specificity of H-2 restricted cytotoxicity may argue for the
differentiation of idiotypically homogeneous clones of T cells during the response to
antigens which can only be seen by T cells in association with selfH-2. In contrast, an
anti-H-2 cytotoxic response may be extremely heterogeneous, consisting of clones of
cells with many different specificities, even though a majority may be directed against
haplotype-specific private antigens recognized by T cells. Experiments where target
cell specificity of putatively individualclones of cytotoxic T cells have been examined
also suggest that cross-reactivity lies at the level of different clones having different
specificities, rather than any one clone having several different target specificities (18) .
Our use ofH-2b mutant strains to elicit cytotoxicity with H-26 mice provides evidence
that the cytotoxic cross-reactivities seen are due to antigens on K or D end coded
molecules, rather than la antigens. However, the complication of cytotoxic responses
to public la antigens being generated whenever responses are elicited across the whole
MHC cannot be excluded, especially because it is known that cytotoxic cells can be
generated between strains just differing at various parts of the I region (19, 20).
If indeed H-2 restricted responses are idiotypically homogeneous while anti-H-2
responses are heterogeneous, then what is the biological significance of these differ-
ences? It has been suggested that the raison d'etre of H-2K and D antigens is to
provide appropriate associative antigens for H-2 restricted responses, which may be
of vital biological importance to recovery from virus infections (14) . The duplication
of genes during the phylogeny of the major histocompatibility complex (MHC), to
provide at least two sets of antigens, K and D, as well as the extraordinary polymor-
phism of H-2K and D antigens, argues for a specialized function of each allelic
product, and perhaps this specialization (specificity) provides the fine discriminatory
properties observed for the MHC.
In contrast, anti-H-2 responses, both in vivo and in vitro, can hardly have any
evolutionary or survival value, because it is unlikely that they have been elicited
before the 20th century, unless they play a role in fetomaternal relationships as has
been proposed (21) . Thus anti-H-2 responses may be an accident, their magnitude a
mere reflection of underlying and important anti-altered self responses, and therefore
the question of their specificity is not important, nor are they very specific.
Summary
Cross-reactive T-cell cytotoxicity is seen when cytotoxic responses are generated in
mixed lymphocyte cultures either between mouse strains which differ at the major1486
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histocompatibility complex, H-2, or between H-2° mutant strains and the strain from
which they were derived. This cross-reactivity can be measured with ["Cr] labeled
target cells from a number of different H-2 haplotypes, and the pattern of cross-
reaction indicates that the target antigens are unlikely to be any of the serologically
defined public specificities. In contrast, the specificity of H-2 restricted cytotoxic
responses, such as that to the male-specific antigen, H-Y, is exquisite, and male cells
from strains of mice carrying H-2 haplotypes other than the responder have never
been found to act as appropriate targets. The contrast between the specificity of anti-
H-2 and H-2 restricted responses may argue for a greater idiotypic homogeneity of
the cells making H-2 restricted responses, and the greater specificity of these responses
may be necessary for their biological function .
Receivedforpublication 7August 1978.
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